Cardiac myosin binding protein-C: A novel sarcomeric target for gene therapy

Pflugers Archiv European Journal of Physiology

Volumn 466, Issue 2, 2014, Pages 225-230

  Mamidi, Ranganath ^a   Li, Jiayang ^a   Gresham, Kenneth S ^a   Stelzer, Julian E ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac myosin binding protein C; Contractile dysfunction; Gene therapy; Hypertrophic cardiomyopathy

Indexed keywords

CARDIOMYOPATHY, HYPERTROPHIC; CARRIER PROTEINS; GENETIC THERAPY; HUMANS; MYOCARDIAL CONTRACTION; MYOCARDIUM; MYOFIBRILS; SARCOMERES;

EID: 84893853895     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/s00424-013-1412-z     Document Type: Review

References (35)

1. Carrier L, Schlossarek S, Willis MS, Eschenhagen T (2010) The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy. Cardiovasc Res 85:330-338
2. Chatterjee K, Massie B (2007) Systolic and diastolic heart failure: differences and similarities. J Card Fail 13:569-576 (Pubitemid 47362750)
3. Chen PP, Patel JR, Powers PA, Fitzsimons DP, Moss RL (2012) Dissociation of structural and functional phenotypes in cardiac myosin-binding protein C conditional knockout mice. Circulation 126:1194-1205
4. Cheng Y, Wan X, McElfresh TA, Chen X, Gresham KS, Rosenbaum DS, Chandler MP, Stelzer JE (2013) Impaired contractile function due to decreased cardiac myosin binding protein C content in the sarcomere. Am J Physiol Heart Circ Physiol 305:H52-H65
5. Copeland O, Sadayappan S, Messer AE, Steinen GJ, van der Velden J, Marston SB (2010) Analysis of cardiac myosin binding protein-C phosphorylation in human heart muscle. J Mol Cell Cardiol 49:1003-1011
6. Coulton AT, Stelzer JE (2012) Cardiac myosin binding protein C and its phosphorylation regulate multiple steps in the cross-bridge cycle of muscle contraction. Biochemistry 51:3292-3301
7. Davis J, Westfall MV, Townsend D, Blankinship M, Herron TJ, Guerrero-Serna G, Wang W, Devaney E, Metzger JM (2008) Designing heart performance by gene transfer. Physiol Rev 88:1567-1651
8. Day SM, Westfall MV, Fomicheva EV, Hoyer K, Yasuda S, La Cross NC, D'Alecy LG, Ingwall JS, Metzger JM (2006) Histidine button engineered into cardiac troponin I protects the ischemic and failing heart. Nat Med 12:181-189 (Pubitemid 43214744)
9. De Lange WJ, Grimes AC, Hegge LF, Spring AM, Brost TM, Ralphe JC (2013) E258K HCM-causing mutation in cardiac MyBP-C reduces contractile force and accelerates twitch kinetics by disrupting the cMyBP-C and myosin S2 interaction. J Gen Physiol 142:241-255
10. Desjardins CL, Chen Y, Coulton AT, Hoit BD, Yu X, Stelzer JE (2012) Cardiac myosin binding protein C insufficiency leads to early onset of mechanical dysfunction. Circ Cardiovasc Imaging 5:127-136
11. Gupta MK, Gulick J, James J, Osinska H, Lorenz JN, Robbins J (2013) Functional dissection of myosin binding protein C phosphorylation. J Mol Cell Cardiol 64:39-50
12. Hajjar RJ (2013) Potential of gene therapy as a treatment for heart failure. J Clin Invest 123:53-61
13. Harris SP, Bartley CR, Hacker TA, McDonald KS, Douglas PS, Greaser ML, Powers PA, Moss RL (2002) Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice. Circ Res 90:594-601 (Pubitemid 34640910)
14. Harris SP, Lyons RG, Bezold KL (2011) In the thick of it: HCM-causing mutations in myosin binding proteins of the thick filament. Circ Res 108:751-764
15. Hasenfuss G, Teerlink JR (2011) Cardiac inotropes: current agents and future directions. Eur Heart J 32:1838-1845
16. Herron TJ, Devaney E, Mundada L, Arden E, Day S, Guerrero-Serna G, Turner I, Westfall M, Metzger JM (2010) Ca2+-independent positive molecular inotropy for failing rabbit and human cardiac muscle by alpha-myosin motor gene transfer. FASEB J 24:415-424
17. Kuster DW, Bawazeer AC, Zaremba R, Goebel M, Boontje NM, van der Velden J (2012) Cardiac myosin binding protein C phosphorylation in cardiac disease. J Muscle Res Cell Motil 33:43-52
18. Malik FI, Hartman JJ, Elias KA et al (2011) Cardiac myosin activation: a potential therapeutic approach for systolic heart failure. Science 331:1439-1443
19. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE (1995) Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 92:785-789
20. Marston S, Copeland O, Jacques A, Livesey K, Tsang V, McKenna WJ, Jalilzadeh S, Carballo S, Redwood C, Watkins H (2009) Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency. Circ Res 105:219-222
21. Merkulov S, Chen X, Chandler MP, Stelzer JE (2012) In vivo cardiac myosin binding protein C gene transfer rescues myofilament contractile dysfunction in cardiac myosin binding protein C null mice. Circ Heart Fail 5:635-644
22. Morita H, Nagai R, Seidman JG, Seidman CE (2010) Sarcomere gene mutations in hypertrophy and heart failure. J Cardiovasc Transl Res 3:297-303
23. Nagayama T, Takimoto E, Sadayappan S, Mudd JO, Seidman JG, Robbins J, Kass DA (2007) Control of in vivo left ventricular [correction] contraction/relaxation kinetics by myosin binding protein C: protein kinase A phosphorylation dependent and independent regulation. Circulation 116:2399-2408 (Pubitemid 350145075)
24. Olivotto I, Girolami F, Ackerman MJ, Nistri S, Bos JM, Zachara E, Ommen SR, Theis JL, Vaubel RA, Re F, Armentano C, Poggesi C, Torricelli F, Cecchi F (2008) Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy. Mayo Clin Proc 83:630-638 (Pubitemid 351810562)
25. Page SP, Kounas S, Syrris P, Christiansen M, Frank-Hansen R, Andersen PS, Elliott PM, McKenna WJ (2012) Cardiac myosin binding protein-C mutations in families with hypertrophic cardiomyopathy: disease expression in relation to age, gender, and long term outcome. Circ Cardiovasc Genet 5:156-166
26. Palmer BM, Sadayappan S, Wang Y, Weith AE, Previs MJ, Bekyarova T, Irving TC, Robbins J, Maughan DW (2011) Roles for cardiac MyBP-C in maintaining myofilament lattice rigidity and prolonging myosin cross-bridge lifetime. Biophys J 101:1661-1669
27. Previs MJ, Beck Previs S, Gulick J, Robbins J, Warshaw DM (2012) Molecular mechanics of cardiac myosin-binding protein C in native thick filaments. Science 337:1215-1218
28. Roger VL, Go AS, Lloyd-Jones DM, American Heart Association Statistics C, Stroke Statistics S et al (2012) Heart disease and stroke statistics - 2012 update: a report from the American Heart Association. Circulation 125:e2-e220
29. Sadayappan S, de Tombe PP (2012) Cardiac myosin binding protein-C: redefining its structure and function. Biophys Rev 4:93-106
30. Shaffer JF, Kensler RW, Harris SP (2009) The myosin-binding protein C motif binds to F-actin in a phosphorylation-sensitive manner. J Biol Chem 284:12318-12327
31. Teerlink JR (2009) A novel approach to improve cardiac performance: cardiac myosin activators. Heart Fail Rev 14:289-298
32. Teerlink JR, Clarke CP, Saikali KG, Lee JH, Chen MM, Escandon RD, Elliott L, Bee R, Habibzadeh MR, Goldman JH, Schiller NB, Malik FI, Wolff AA (2011) Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study. Lancet 378:667-675
33. van Dijk SJ, Dooijes D, dos Remedios C, Michels M, Lamers JM, Winegrad S, Schlossarek S, Carrier L, ten Cate FJ, Stienen GJ, van der Velden J (2009) Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction. Circulation 119:1473-1483
34. Waldmuller S, Erdmann J, Binner P, German Competence Network Heart F et al (2011) Novel correlations between the genotype and the phenotype of hypertrophic and dilated cardiomyopathy: results from the German Competence Network Heart Failure. Eur J Heart Fail 13:1185-1192
35. Xie M, Burchfield JS, Hill JA (2013) Pathological ventricular remodeling: therapies: part 2 of 2. Circulation 128:1021-1030